Covid Nasal Vaccine

The clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine have been completed and the company will submit its data to the Drugs Controller General of India (DCGI) next month, Dr Krishna Ella, Chairman and Managing…
Read More...